Citation Impact
Citing Papers
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
2003 StandoutNobel
Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 + T Lymphocytes
2008 StandoutScienceNobel
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Aire-Dependent Thymic Development of Tumor-Associated Regulatory T Cells
2013 StandoutScienceNobel
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Tumor Evasion of the Immune System by Converting CD4+CD25− T Cells into CD4+CD25+ T Regulatory Cells: Role of Tumor-Derived TGF-β
2007
Hallmarks of Cancer: The Next Generation
2011 Standout
Cancer immunoediting: from immunosurveillance to tumor escape
2002 Standout
Combinatorial Cancer Immunotherapy
2006
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Inflammation and cancer
2002 StandoutNature
Tumor infiltrating Foxp3+ regulatory T‐cells are associated with recurrence in pathologic stage I NSCLC patients
2006
Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma
2007
Molecular Mechanisms of Human Hypertension
2001 Standout
Dermatologist-level classification of skin cancer with deep neural networks
2017 StandoutNature
Estrogen Deficiency Increases the Ability of Stromal Cells to Support Murine Osteoclastogenesis via an Interleukin-1and Tumor Necrosis Factor-mediated Stimulation of Macrophage Colony-stimulating Factor Production
1996
Angiogenesis in cancer and other diseases
2000 StandoutNature
Immunology and immunotherapy of colorectal cancer
2003
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
1997 Standout
Immune surveillance of tumors
2007
Immune infiltration in human tumors: a prognostic factor that should not be ignored
2009
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?
2011
Immunity, Inflammation, and Cancer
2010 Standout
Cytokines in cancer pathogenesis and cancer therapy
2004
Vascular-specific growth factors and blood vessel formation
2000 StandoutNature
Cancer immunotherapy comes of age
2011 StandoutNature
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
1994 Standout
Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.
1996 Standout
What do we mean by validating a prognostic model?
2000
Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer
1997
Cytokine-secreting tumor cell vaccines
2000
Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer
1993
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
Cancer-related inflammation
2008 StandoutNature
The importance of clinical research: the role of thermogenesis in human obesity
2001
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
2011 StandoutNobel
Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma
1996
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
βAR Signaling Required for Diet-Induced Thermogenesis and Obesity Resistance
2002 StandoutScienceNobel
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
The Three Es of Cancer Immunoediting
2004 Standout
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
1997 StandoutScience
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Bone Resorption by Osteoclasts
2000 StandoutScience
Abnormal Vascular Function and Hypertension in Mice Deficient in Estrogen Receptor β
2002 StandoutScienceNobel
Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
2003
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction
2003
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
Socioeconomic status and obesity: A review of the literature.
1989 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
2007 StandoutNobel
Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors
2005
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Deep Learning—A Technology With the Potential to Transform Health Care
2018 StandoutNobel
Overall survival and PD‐L1 expression in metastasized malignant melanoma
2010
Neoantigens in cancer immunotherapy
2015 StandoutScience
Computer Aided Diagnostic Support System for Skin Cancer: A Review of Techniques and Algorithms
2013
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
Immune recognition and tumor protection
2002
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody
2018 StandoutNobel
Works of Leonard E. Braitman being referenced
Severe mitral annular calcification predicts chronic kidney disease
2007
Mitral Annular Calcium Causing Mitral Stenosis
2009
Model Predicting Survival in Stage I Melanoma Based on Tumor Progression
1989 Standout
Development and validation of a model to diagnose cirrhosis in patients with hepatitis C
2002
Demographic, dietary, life style, and anthropometric correlates of blood pressure.
1982
Statistical Power Analysis in Medical Research
1983
Predicting Clinical States in Individual Patients
1996
Obesity and caloric intake: The national Health and Nutrition Examination Survey of 1971–1975 (HANES I)
1985